Literature DB >> 29992733

Monitoring chemotherapy-induced alopecia with trichoscopy.

Alfredo Rossi1, Maria Caterina Fortuna1, Gemma Caro1, Michele Cardone1, Valentina Garelli1, Sara Grassi2, Marta Carlesimo1.   

Abstract

BACKGROUND: Chemotherapy-induced alopecia (CIA) ranks among the psychologically most devastating effects of cancer treatment for oncological patients, with an overall incidence of 65%. Nowadays trichoscopy is largely employed in the diagnosis of alopecia, but no description of CIA trichoscopic pattern is present in literature. AIMS: We want to create an organic description of CIA trichoscopic aspects.
METHODS: Oncological patients candidate to chemotherapy drugs, afferent to our trichological outpatient were studied. Anamnesis, clinical exam, clinical global photography, pull test, trichogram, and trichoscopy were conducted at the different moments of therapeutic treatment.
RESULTS: A definite trichoscopic pattern in the different phases of treatment was observed. After the first 3 weeks of chemotherapy rare and scattered black dots, broken hairs, flame hairs and pohl pinkus appeared. At the end of chemotherapy besides the features described above, numerous thin hair in regrowth were detected, together to rare terminal hair, scattered black dots and circle hair. Three months after chemotherapy a progressive increase of follicular units and elongation of the existing hair were visible.
CONCLUSIONS: We propose an description of CIA trichoscopic pattern and its evolution during the different phases of chemotherapy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  alopecia; chemotherapy; hair loss; skin reactions; trichoscopy

Year:  2018        PMID: 29992733     DOI: 10.1111/jocd.12687

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  7 in total

Review 1.  Prevention and Treatment of Chemotherapy-Induced Alopecia.

Authors:  Alfredo Rossi; Gemma Caro; Maria Caterina Fortuna; Flavia Pigliacelli; Andrea D'Arino; Marta Carlesimo
Journal:  Dermatol Pract Concept       Date:  2020-06-29

2.  Vismodegib-Induced Alopecia: Trichoscopic and Confocal Microscopy Evaluation.

Authors:  Mariateresa Cantelli; Milena Cappello; Maria Vastarella; Angela Patrì; Massimiliano Scalvenzi; Gabriella Fabbrocini
Journal:  Skin Appendage Disord       Date:  2020-09-09

3.  Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question.

Authors:  Alfredo Rebora; Marcella Guarrera
Journal:  Skin Appendage Disord       Date:  2021-05-06

Review 4.  Scalp cooling to prevent chemotherapy-induced alopecia.

Authors:  Giselle de Barros Silva; Kathryn Ciccolini; Aline Donati; Corina van den Hurk
Journal:  An Bras Dermatol       Date:  2020-06-16       Impact factor: 1.896

5.  Cutaneous T-cell lymphoma in erythrodermic cases may be suspected on the basis of scalp examination with dermoscopy.

Authors:  Adriana Rakowska; Magdalena Jasińska; Mariusz Sikora; Joanna Czuwara; Patrycja Gajda-Mróz; Olga Warszawik-Hendzel; Małgorzata Kwiatkowska; Anna Waśkiel-Burnat; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

6.  Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID-19.

Authors:  Nasrin Saki; Fatemeh Sari Aslani; Mozhdeh Sepaskhah; Mohadese Shafiei; Sara Alavizadeh; Seyed Ali Hosseini; Fatemeh Ansari Asl; Najmeh Ahramiyanpour
Journal:  Clin Case Rep       Date:  2022-08-09

7.  Diagnostic Accuracy of Trichoscopy in Trichotillomania: A Systematic Review.

Authors:  Agnieszka Kaczorowska; Lidia Rudnicka; Catherine M Stefanato; Anna Waskiel-Burnat; Olga Warszawik-Hendzel; Malgorzata Olszewska; Adriana Rakowska
Journal:  Acta Derm Venereol       Date:  2021-10-07       Impact factor: 3.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.